FTC sues three largest drug middlemen for allegedly inflating insulin prices

  • Posted on September 20, 2024
  • By The Hill
  • 4 Views
FTC sues three largest drug middlemen for allegedly inflating insulin prices

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially”…
continue reading...

Author
The Hill

You May Also Like